Kukucka Jessica, Wyllie Tessa, Read Justin, Mahoney Lauren, Suphioglu Cenk
Biomol Concepts. 2013 Aug;4(4):319-33. doi: 10.1515/bmc-2012-0053.
Histone acetyltransferases (HATs) and histone deacetylases (HDACs) promote histone posttranslational modifications, which lead to an epigenetic alteration in gene expression. Aberrant regulation of HATs and HDACs in neuronal cells results in pathological consequences such as neurodegeneration. Alzheimer's disease is the most common neurodegenerative disease of the brain, which has devastating effects on patients and loved ones. The use of pan-HDAC inhibitors has shown great therapeutic promise in ameliorating neurodegenerative ailments. Recent evidence has emerged suggesting that certain deacetylases mediate neurotoxicity, whereas others provide neuroprotection. Therefore, the inhibition of certain isoforms to alleviate neurodegenerative manifestations has now become the focus of studies. In this review, we aimed to discuss and summarize some of the most recent and promising findings of HAT and HDAC functions in neurodegenerative diseases.
组蛋白乙酰转移酶(HATs)和组蛋白去乙酰化酶(HDACs)促进组蛋白的翻译后修饰,从而导致基因表达的表观遗传改变。神经元细胞中HATs和HDACs的异常调节会导致诸如神经退行性变等病理后果。阿尔茨海默病是最常见的脑部神经退行性疾病,对患者及其亲人具有毁灭性影响。使用泛HDAC抑制剂在改善神经退行性疾病方面已显示出巨大的治疗前景。最近有证据表明,某些去乙酰化酶介导神经毒性,而其他一些则提供神经保护作用。因此,抑制某些亚型以减轻神经退行性表现现已成为研究的焦点。在本综述中,我们旨在讨论和总结HAT和HDAC在神经退行性疾病中的功能的一些最新且有前景的发现。